PDS Biotechnology Corporation
PDSB
$0.82
$0.056.44%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -9.01M | -9.43M | -8.49M | -7.95M | -10.73M |
| Total Depreciation and Amortization | 15.10K | 15.10K | 15.10K | 15.10K | 15.10K |
| Total Amortization of Deferred Charges | -307.20K | 1.11M | 272.60K | 297.80K | 305.10K |
| Total Other Non-Cash Items | 2.00M | 448.00K | 1.46M | 1.64M | 1.78M |
| Change in Net Operating Assets | 1.39M | -1.24M | -2.29M | -2.24M | 628.40K |
| Cash from Operations | -5.92M | -9.10M | -9.03M | -8.23M | -8.00M |
| Capital Expenditure | -- | -- | -- | 0.00 | 0.00 |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | 0.00 | 0.00 |
| Total Debt Issued | 0.00 | 19.24M | -- | -- | -- |
| Total Debt Repaid | -1.02M | -19.70M | -3.14M | -3.14M | -14.10K |
| Issuance of Common Stock | 1.26M | 1.46M | 7.30M | 3.31M | 31.30K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00 | 0.00 | 3.16M | -- | -- |
| Cash from Financing | 241.20K | 995.90K | 7.32M | 172.80K | 17.20K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -5.67M | -8.11M | -1.71M | -8.06M | -7.98M |